Remove Physicians Remove Safety Remove Side effects
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

They research the drug online and ask their physician about it if they decide it’s a treatment option. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.” Again this is not true.

Marketing 285
article thumbnail

Consumers fall into three COVID-19 vaccine adoption segments

World of DTC Marketing

These are consumers who have relatively firm personal conviction in their decision to get vaccinated and may well be “first in line” when a vaccine is available to them—assuming continued positive safety and efficacy evidence. Importantly, they want to receive information from trusted sources, namely physicians.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is DTC effective?

World of DTC Marketing

How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? What are the side effects? They’re going to go online where they can read the safety warnings that too often than not scare them because they lack context.

article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. During the two-year project, the companies will assess the mental health side effects of the asthma drug, montelukast.

Safety 59
article thumbnail

The Future of Biosimilars Marketing

PM360

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.

article thumbnail

MHRA warns of serious eye-related adverse events after Dupixent use

Pharmaceutical Technology

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

article thumbnail

Medical Sales Strategies: How to Drive Doctors’ Recommendations

MaBiCo

Whether you are in the pharmaceuticals, dermoceuticals, OTC, medical devices, or whatever business relates with patients and their health, you need to have a clearly defined strategy on how to approach physicians. More specifically clinical trials provide a reliable evaluation for a product’s effectiveness and its side effects on humans.